ZEB2 and cancer: As the characteristic of EMT, cancer cells gradually lose expression of epithelial markers, such as E‐cadherin, whereas some mesenchymal marker expressions are increased including vimentin, N‐cadherin, zinc finger E‐box‐binding homeobox 1 (ZEB1) and ZEB2.11